These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38385211)
1. High-tissue FRMD6 expression predicts better outcomes among colorectal cancer patients. von Koskull A; Hagström J; Haglund C; Kaprio T; Böckelman C Biomarkers; 2024 May; 29(3):127-133. PubMed ID: 38385211 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer. Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498 [TBL] [Abstract][Full Text] [Related]
4. High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients. Beilmann-Lehtonen I; Hagström J; Mustonen H; Koskensalo S; Haglund C; Böckelman C Oncology; 2021; 99(9):589-600. PubMed ID: 34139707 [TBL] [Abstract][Full Text] [Related]
5. Podocalyxin is a marker of poor prognosis in colorectal cancer. Kaprio T; Fermér C; Hagström J; Mustonen H; Böckelman C; Nilsson O; Haglund C BMC Cancer; 2014 Jul; 14():493. PubMed ID: 25004863 [TBL] [Abstract][Full Text] [Related]
6. FRMD6 has tumor suppressor functions in prostate cancer. Haldrup J; Strand SH; Cieza-Borrella C; Jakobsson ME; Riedel M; Norgaard M; Hedensted S; Dagnaes-Hansen F; Ulhoi BP; Eeles R; Borre M; Olsen JV; Thomsen M; Kote-Jarai Z; Sorensen KD Oncogene; 2021 Jan; 40(4):763-776. PubMed ID: 33249427 [TBL] [Abstract][Full Text] [Related]
7. Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer. Ma C; Jin RM; Chen KJ; Hao T; Li BS; Zhao DH; Jiang H Pathol Res Pract; 2018 May; 214(5):661-666. PubMed ID: 29653744 [TBL] [Abstract][Full Text] [Related]
8. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy. Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332 [TBL] [Abstract][Full Text] [Related]
9. FERM domain-containing protein 6 identifies a subpopulation of varicose nerve fibers in different vertebrate species. Beck J; Kressel M Cell Tissue Res; 2020 Jul; 381(1):13-24. PubMed ID: 32200438 [TBL] [Abstract][Full Text] [Related]
10. Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer. Larsson A; Fridberg M; Gaber A; Nodin B; Levéen P; Jönsson G; Uhlén M; Birgisson H; Jirström K BMC Cancer; 2012 Jul; 12():282. PubMed ID: 22769594 [TBL] [Abstract][Full Text] [Related]
11. Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry. Trinh A; Trumpi K; De Sousa E Melo F; Wang X; de Jong JH; Fessler E; Kuppen PJ; Reimers MS; Swets M; Koopman M; Nagtegaal ID; Jansen M; Hooijer GK; Offerhaus GJ; Kranenburg O; Punt CJ; Medema JP; Markowetz F; Vermeulen L Clin Cancer Res; 2017 Jan; 23(2):387-398. PubMed ID: 27459899 [TBL] [Abstract][Full Text] [Related]
12. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer. Maierthaler M; Benner A; Hoffmeister M; Surowy H; Jansen L; Knebel P; Chang-Claude J; Brenner H; Burwinkel B Int J Cancer; 2017 Jan; 140(1):176-187. PubMed ID: 27632639 [TBL] [Abstract][Full Text] [Related]
13. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer. Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444 [TBL] [Abstract][Full Text] [Related]
14. The prognostic role of tissue TLR2 and TLR4 in colorectal cancer. Beilmann-Lehtonen I; Böckelman C; Mustonen H; Koskensalo S; Hagström J; Haglund C Virchows Arch; 2020 Nov; 477(5):705-715. PubMed ID: 32424768 [TBL] [Abstract][Full Text] [Related]
15. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242. Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125 [TBL] [Abstract][Full Text] [Related]
16. Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers. Cheng X; Tian X; Wu X; Xing X; Du H; Zhou C; Zhang Q; Hao C; Wen X; Ji J PLoS One; 2016; 11(7):e0158715. PubMed ID: 27391361 [TBL] [Abstract][Full Text] [Related]
17. DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis. Feng X; Liu J; Gong Y; Gou K; Yang H; Yuan Y; Xing C Cancer Med; 2018 Jun; 7(6):2339-2349. PubMed ID: 29675892 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer. Yuan Y; Qi G; Shen H; Guo A; Cao F; Zhu Y; Xiao C; Chang W; Zheng S Int J Cancer; 2019 Apr; 144(7):1584-1595. PubMed ID: 29987896 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma. Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544 [TBL] [Abstract][Full Text] [Related]
20. Low NLRP3 expression predicts a better prognosis of colorectal cancer. Shi F; Wei B; Lan T; Xiao Y; Quan X; Chen J; Zhao C; Gao J Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33821998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]